Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

iCAD, Inc. (ICAD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.71-0.09 (-1.15%)
At close: 1:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close7.80
Open7.66
Bid7.69 x 1000
Ask8.99 x 800
Day's Range7.51 - 7.82
52 Week Range7.51 - 21.44
Volume112,635
Avg. Volume164,167
Market Cap193.593M
Beta (5Y Monthly)1.01
PE Ratio (TTM)N/A
EPS (TTM)-0.37
Earnings DateFeb 22, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.88
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ICAD

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • icad inc.
    Weekly Stock ListVickers Stock Research, a subsidiary of Argus Research Group, tracks and analyzes insider trading and institutional ownership trends. Form 13-Fs are due 45 days after the end of calendar quarters, and have now come in from 2Q21. We like to review the 13Fs of the major activist investors, including Carl Icahn, Trian Fund Management, Jana Partners, and ValueAct Holdings, among others. Activist investing has evolved in recent years and is now less about generating a short-term return on an underpriced stock and more about achieving long-term returns through an active management/investor partnership. Here are some recent new purchases and key holdings of activist investors, according to Vickers.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • GlobeNewswire

    iCAD to Participate in the 12th Annual Craig-Hallum Alpha Select Conference

    NASHUA, N.H., Nov. 11, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will participate in the 12th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 16, 2021, starting at 9:00 AM ET. Management will be available to host virtual one-on-one meetings with investors who are registered to attend the conference. For more information, please visit Craig-Hallum.com.

  • GlobeNewswire

    iCAD to Host 2nd Annual Virtual Investor Webinar on Company’s Innovative Solutions for Cancer Detection and Treatment

    Leading clinical and administrative experts to discuss how leveraging iCAD’s Breast Health Solutions and the Xoft System can enhance clinical efficiency and improve outcomes for patients Webinar taking place on Thursday, November 18 from 3:00 to 4:30 PM ET NASHUA, N.H., Nov. 11, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will host its 2nd annual virtual investor webinar, fe

  • Motley Fool

    iCAD (ICAD) Q3 2021 Earnings Call Transcript

    Joining us today from iCAD are Michael Klein, chairman and chief executive officer; Stacey Stevens, president; and Charles Carter, chief financial officer. Earlier this afternoon, iCAD announced financial results for the three and nine months ended September 30, 2021, in a press release, which is also available on the iCAD website.

Advertisement
Advertisement